All Stories

  1. P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift?

    Article • Current Vascular Pharmacology, January 2024, Bentham Science Publishers

    Felice Gragnano

  2. Role of dual lipid-lowering therapy in coronary atherosclerosis regression: Evidence from recent studies

    Article • Atherosclerosis, February 2018, Elsevier

    Felice Gragnano